Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA

Molecular Cell

Volumn 12, Issue 6, 2003, Pages 1413-1426

  Ryo, Akihide ^a,b   Suizu, Futoshi ^a   Yoshida, Yasuhiro ^c   Perrem, Kilian ^a,f   Liou, Yih Cherng ^a,g   Wulf, Gerburg ^a   Rottapel, Robert ^d   Yamaoka, Shoji ^e   Lu, Kun Ping ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d UNIVERSITY OF TORONTO   (Canada)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f BEAUMONT HOSPITAL   (Ireland)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOMERASE; PEPTIDYL PROLYL ISOMERASE; PROLINE; SUPPRESSOR OF CYTOKINE SIGNALING 1; SYNAPTOTAGMIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHUK PROTEIN, HUMAN; CHUK PROTEIN, MOUSE; DNA BINDING PROTEIN; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, HUMAN; IKBKE PROTEIN, MOUSE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; PROTEIN SERINE THREONINE KINASE; PROTEIN SUBUNIT; REPRESSOR PROTEIN; SIGNAL PEPTIDE; SOCS1 PROTEIN, HUMAN; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR RELA;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENZYME BINDING; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOMERIZATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; FEMALE; FIBROBLAST; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TRANSACTIVATION;

ANIMALIA;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; BREAST NEOPLASMS; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NF-KAPPA B; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; UBIQUITIN;

EID: 0347955360     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00490-8     Document Type: Article

References (44)

1. Ayala G., Wang D., Wulf G., Frolov A., Le R., Wheeler T., Sowadski J.M., Lu K.P., Bao L. Pin1 is a novel prognostic marker in prostate cancer. Cancer Res. 4:2003;175-180.
2. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107:2001;241-246.
3. Bannerman D.D., Tupper J.C., Kelly J.D., Winn R.K., Harlan J.M. The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta. J. Clin. Invest. 109:2002;419-425.
4. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:1995;167-170.
5. Bhat-Nakshatri P., Sweeney C.J., Nakshatri H. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. Oncogene. 21:2002;2066-2078.
6. Brantley D.M., Chen C.L., Muraoka R.S., Bushdid P.B., Bradberry J.L., Kittrell F., Medina D., Matrisian L.M., Kerr L.D., Yull F.E. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell. 12:2001;1445-1455.
7. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V., Karin M. IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell. 107:2001;763-775.
8. Chaisson M.L., Brooling J.T., Ladiges W., Tsai S., Fausto N. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J. Clin. Invest. 110:2002;193-202.
9. Chen L., Fischle W., Verdin E., Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 293:2001;1653-1657.
10. Dadd C.A., Cook R.G., Allis C.D. Fractionation of small tryptic phosphopeptides by alkaline PAGE followed by amino acid sequencing. Biotechniques. 14:1993;266-274.
11. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H.et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
12. Frantsve J., Schwaller J., Sternberg D.W., Kutok J., Gilliland D.G. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21:2001;3547-3557.
13. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell Suppl. 109:2002;S81-S96.
14. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell. 95:1998;759-770.
15. Jacobs M.D., Harrison S.C. Structure of an IκBα/NF-κB complex. Cell. 95:1998;749-758.
16. Kamizono S., Hanada T., Yasukawa H., Minoguchi S., Kato R., Minoguchi M., Hattori K., Hatakeyama S., Yada M., Morita S.et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276:2001;12530-12538.
17. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer. from innocent bystander to major culprit Nat. Rev. Cancer. 2:2002;301-310.
18. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:2002;583-591.
19. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734.
20. Li Q., Estepa G., Memet S., Israel A., Verma I.M. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice. additional defect in neurulation Genes Dev. 14:2000;1729-1733.
21. Liou Y.C., Ryo R., Huang H.K., Lu P.J., Bronson R., Fujimori F., Uchida T., Hunter T., Lu K.P. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA. 99:2002;1335-1340.
22. Lu K.P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell. 4:2003;175-180.
23. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature. 380:1996;544-547.
24. Lu P.J., Zhou X.Z., Shen M., Lu K.P. A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 283:1999;1325-1328.
25. Lu K.P., Liou Y.C., Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12:2002;164-172.
26. Miyamoto S., Chiao P.J., Verma I.M. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell. Biol. 14:1994;3276-3282.
27. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K.et al. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
28. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K.et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:2002;677-687.
29. Nakshatri H., Goulet R.J. Jr. NF-kappaB and breast cancer. Curr. Probl. Cancer. 26:2002;282-309.
30. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
31. Rottapel R., Ilangumaran S., Neale C., La Rose J., Ho J.M., Nguyen M.H., Barber D., Dubreuil P., de Sepulveda P. The tumor suppressor activity of SOCS-1. Oncogene. 21:2002;4351-4362.
32. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A.J., Mak T.W. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:2000;854-862.
33. Ryo A., Nakamura N., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:2001;793-801.
34. Ryo A., Liou Y.C., Wulf G., Nakamura M., Lee S.W., Lu K.P. Pin1 Is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:2002;5281-5295.
35. Ryo A., Liou Y.C., Lu K.P., Wulf G. Prolyl isomerase Pin1. a catalyst for oncogenesis and a potential therapeutic target in cancer J. Cell Sci. 116:2003;773-783.
36. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791.
37. Ungureanu D., Saharinen P., Junttila I., Hilton D.J., Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:2002;3316-3326.
38. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Lu K.P. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J. 20:2001;3459-3472.
39. Wulf G.M., Liou Y.C., Ryo A., Lee S.W., Lu K.P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:2002;47976-47979.
40. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J., Xu J., Kuang J., Kirschner M.W., Fischer G.et al. Sequence-specific and phosphorylation-dependent proline isomerization. a potential mitotic regulatory mechanism Science. 278:1997;1957-1960.
41. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
42. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:2001;29-35.
43. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., Gu L., Tang X., Lu K.P., Xiao Z.X. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature. 419:2002;849-853.
44. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.